Amsterdam Public Health
-
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
de Jonge, A. V., van Werkhoven, E., Dinmohamed, A. G., Nijland, M., Zwinderman, A. H., Bossuyt, P. M., Veldhuis, M. S., Rutten, E. G. G. M., Mous, R., Vermaat, J. S. P., Sandberg, Y., de Jongh, E., Bilgin, Y. M., Boersma, R., Koene, H., Kersten, M. J., de Jong, D. & Chamuleau, M. E. D., 1 Dec 2023, In: Blood Cancer Journal. 13, 1, 85.Research output: Contribution to journal › Article › Academic › peer-review
-
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
Vliek, S., Hilbers, F. S., van Werkhoven, E., Mandjes, I., Kessels, R., Kleiterp, S., Lips, E. H., Mulder, L., Kayembe, M. T., Loo, C. E., Russell, N. S., Vrancken Peeters, M-J. T. F. D., Holtkamp, M. J., Schot, M., Baars, J. W., Honkoop, A. H., Vulink, A. J. E., Imholz, A. L. T., Vrijaldenhoven, S., van den Berkmortel, F. W. P. J., & 11 others , 1 Dec 2023, In: NPJ Breast Cancer. 9, 1, 75.Research output: Contribution to journal › Article › Academic › peer-review
-
Immediate or delayed oncoplastic surgery after breast conserving surgery at the Netherlands Cancer Institute: a cohort study of 251 cases
van Loevezijn, A. A., Geluk, C. S., van den Berg, M. J., van Werkhoven, E. D., Vrancken Peeters, M-J. T. F. D., van Duijnhoven, F. H. & Hoornweg, M. J., Apr 2023, In: Breast cancer research and treatment. 198, 2, p. 295-307 13 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications